TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 123,250 Value ($000) $2,946 Avg Close $18.80 Range $14.36 - $28.69

Q2 2025

Shares 380,997 Value ($000) $5,639 Avg Close $16.57 Range $12.91 - $22.07

Q2 2024

Shares 47,573 Value ($000) $391 Avg Close $6.73 Range $5.12 - $8.38

Q1 2024

Shares 47,573 Value ($000) $367 Avg Close $8.44 Range $7.11 - $10.27

Q4 2023

Shares 41,641 Value ($000) $374 Avg Close $7.28 Range $5.25 - $9.70

Q3 2023

Shares 18,339 Value ($000) $164 Avg Close $14.11 Range $7.00 - $17.57

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	123,250	$2,946	$18.80	$14.36 - $28.69
Q2 2025	380,997	$5,639	$16.57	$12.91 - $22.07
Q2 2024	47,573	$391	$6.73	$5.12 - $8.38
Q1 2024	47,573	$367	$8.44	$7.11 - $10.27
Q4 2023	41,641	$374	$7.28	$5.25 - $9.70
Q3 2023	18,339	$164	$14.11	$7.00 - $17.57